Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501) (TOG-SAFRADJU)

Ankara University

Status: Active, not recruiting

Conditions: Biliary Tract Cancers (BTC); Biliary Tract Cancer

Treatments: Drug: Chemotherapy

Study type: Observational

Funder types: Other; NETWORK

Identifiers

NCT06975917

i09-714-24

Details and patient eligibility

About

The goal of this observational study is to compare chemotherapy types that are given after surgery for biliary tract cancers. The main question it aims to answer is:

Are any of the chemotherapy regimens more effective in preventing recurrence, providing longer survival, or having less toxicity?

Nationwide multicenter retrospective data will be collected.

Enrollment: 600 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Histologically confirmed biliary tract cancer (intrahepatic, perihilar, distal, gallbladder)
• Underwent curative-intent resection

Exclusion criteria

• Patients with a disease without histological confirmation
• Ampullary cancers

Trial design

600 participants in 1 patient group

Patient with biliary tract cancer

Description:

Patients with biliary tract cancer, who underwent resection and received adjuvant chemotherapy

Treatment:

Drug: Chemotherapy